Trial · NCT03936777
Adverse events76
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 76
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Any ZX008 Open Label Dose | 29 | 412 | 36 |
| other | Pyrexia | General disorders | Any ZX008 Open Label Dose | 53 | 412 | 86 |
| other | Corona virus infection | Infections and infestations | Any ZX008 Open Label Dose | 84 | 412 | 99 |
| other | Nasopharyngitis | Infections and infestations | Any ZX008 Open Label Dose | 49 | 412 | 69 |
| other | Upper respiratory tract infection | Infections and infestations | Any ZX008 Open Label Dose | 23 | 412 | 28 |
| other | Decreased appetite | Metabolism and nutrition disorders | Any ZX008 Open Label Dose | 25 | 412 | 30 |
| other | Seizure | Nervous system disorders | Any ZX008 Open Label Dose | 52 | 412 | 69 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | Any ZX008 Open Label Dose | 1 | 412 | 3 |
| serious | Cardiac arrest | Cardiac disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Non-compaction cardiomyopathy | Congenital, familial and genetic disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Pyloric stenosis | Congenital, familial and genetic disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Vision blurred | Eye disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Abdominal distension | Gastrointestinal disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Constipation | Gastrointestinal disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Diarrhoea | Gastrointestinal disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Intestinal obstruction | Gastrointestinal disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Asthenia | General disorders | Any ZX008 Open Label Dose | 2 | 412 | 2 |
| serious | Complication associated with device | General disorders | Any ZX008 Open Label Dose | 1 | 412 | 2 |
| serious | Gait disturbance | General disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
| serious | Gait inability | General disorders | Any ZX008 Open Label Dose | 1 | 412 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03936777/events